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Abstract:
BACKGROUND
Statistical reports show that every year around the world approximately 15 million bone fractures occur; of which up to 10% fail to
heal completely and hence lead to complications of non-union healing. In the past, autografts or allografts were used as the “gold
standard” of treating such defects. However, due to various limitations and risks associated with these sources of bone grafts, other
avenues have been extensively investigated through which bone tissue engineering; in particular engineering of synthetic bone graft
substitutes, has been recognised as a promising alternative to the traditional methods.
METHODS
A selective literature search was performed.
RESULTS
Bone tissue engineering offers unlimited supply, eliminated risk of disease transmission and relatively low cost. It could also lead to
patient specific design and manufacture of implants, prosthesis and bone related devices. A potentially promising building block for a
suitable scaffold is synthetic nanohydroxyapatite incorporated into synthetic polymers. Incorporation of nanohydroxyapatite into
synthetic polymers has shown promising bioactivity, osteoconductivity, mechanical properties and degradation profile compared to
other techniques previously considered.
CONCLUSION
Scientific  research,  through extensive physiochemical  characterisation,  in  vitro  and in  vivo  assessment has brought  together  the
optimum characteristics  of  nanohydroxyapatite  and  various  types  of  synthetic  polymers  in  order  to  develop  nanocomposites  of
suitable  nature  for  bone  tissue  engineering.  The  aim  of  the  present  article  is  to  review  and  update  various  aspects  involved  in
incorporation of  synthetic  nanohydroxyapatite  into synthetic  polymers,  in terms of  their  potentials  to promote bone growth and
regeneration in vitro, in vivo and consequently in clinical applications.
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INTRODUCTION
The ever  increasing  worldwide  statistics  of  bone  disorders  and  related  diseases,  in  particular  in  aging  or  obese
populations as well as those with poor physical activity, have raised alarming concerns as studies suggest the incidence
of bone disorder to more than double up by 2020 globally [1, 2]. The current approach towards treating bone defects,
with  the  aim  of  repairing  or  regenerating  bone,  is  the  use  of  bone  grafts  (autografts  or  allografts)  [3  -  5].  So  far,
autografts have been considered as the “gold standard” for the repair of bone defects due to their many characteristics
including their histocompatibility, non-immunogenicity and osteoinductive/osteocunductive potentials [2, 3]. However,
harvesting autografts from patient’s iliac crest, as a second procedure, is considered expensive and risky (leading to
bleeding,  inflammation,  infection  and/or  chronic  pain  in  some  cases)  [6  -  8].  There  are  also  extensive  reports  on
significant donor site injury and morbidity following this procedure [9, 10]. To overcome such obstacles, bone tissue
engineering; in particular engineering of synthetic bone graft substitutes, has been recognised as an alternative to the
traditional  methods.  This  is  mostly  because  of  their  unlimited  supply,  eliminated  risk  of  disease  transmission  and
relatively low cost [2, 11, 12]. Bone tissue engineering could also lead to patient specific design and manufacture of
implants, prosthesis and bone related devices [12, 13].
The principal of bone tissue engineering is based on using natural or synthetic scaffolds that are biocompatible and
similar (mechanically, chemically and biologically) to the native extracellular matrix (ECM) of human bone. In order
for bone to be repaired or regenerated, depending on the design, such scaffolds are seeded with cells with osteogenic
lineages and in some cases incorporated with osteogenic and/or vasculogenic growth factors, or inorganic biomaterials
such as calcium phosphate, hydroxyapatite or bioglasses, to promote bone growth. An ideal scaffold, depending on its
application, should be biocompatible, bioactive, non-thrombogenic and anti-inflammatory. It should also be porous with
interconnected  open  pores  of  suitable  sizes  (macro-pore  size  >100  mm,  micro-pore  size  <20  mm),  to  promote  the
ingrowth of osteogenic cells in vivo [12, 14, 15]. Furthermore, it should have compatible mechanical and controlled
degradation kinetics (if necessary) with the specific application of bone tissue engineering [2, 12]. These characteristics
are normally compared to those of either cortical or trabecular bone, depending on the type of bone defect (Table 1). In
addition  to  the  above  characteristics,  ideal  bone  tissue  engineering  scaffolds,  as  already  mentioned,  should  closely
resemble  the  composition  of  bone  ECM,  which  naturally  consist  of  collagen  (predominantly  type-1  collagen),
carbonated  apatite  mineralites,  and  nanohydroxyapatite  (nHA).
Table 1. Structure and mechanical properties of natural bone.
Structure of the bulk 70% calcium phosphate crystal & 20-30% collagen matrix with some water
Mechanical properties of the collagen matrix E = 1-2 GPa, UTS = 50-1000 MPa
Mechanical properties of the calcium phosphate mineral E = 130 GPa, UTS = 100 MPa
Compressive strength of cortical bone 100-230 MPa
Compressive strength of cancellous bone 2-12 MPa
Young’s modulus of cortical bone 7-30 GPa
Young’s modulus of cancellous bone 0.5-0.005 GPa
In  the  search  for  the  ideal  substitute  material  for  natural  bone,  various  materials  including;  metals,  ceramics,
polymers (natural and synthetic) have been investigated. The main disadvantages of metals and ceramics are that they
lack  degradability  under  biological  conditions  and  that  their  processability  is  extensively  limited  as  opposed  to
polymers, which offer wide design flexibility [16, 17]. Hence, biopolymer composites and nanocomposites have been
investigated as the best approach to mimic natural bone properties and create an ideal artificial scaffolding for bone
regeneration and repair. Chitson (a linear polysaccharide produced by the deacetylation of chitin, a naturally occurring
polymer) based composite biomaterials have been one group of such materials that have attracted considerable attention
for bone tissue engineering purposes, owing to their pore forming ability, binding capacity with anionic molecules,
antibacterial activity and biodegradation [18]. However, on their own, they generally lack the necessary mechanical
properties for bone tissue engineering application. Collagen based nanocomposites have also been greatly investigated
for bone tissue engineering applications. Collagen nanofibrous structure (50-500 nm) can have improving effect on cell
attachment, proliferation and differentiation for bone regeneration. However, the natural and rapid degradability of this
family of materials limits their applications [19]. Other naturally occurring materials used for bone tissue engineering
include gelatine- and fibroin-based nanocomposites. Like the collagen family, these natural polymers also have limited
applications due to the nature and rate of their degradation. Therefore, a thorough search of the literature reveals that
synthetic polymers have been extensively studied as the basic materials for the purpose of fabricating tissue engineered
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scaffolds  with  potentials  to  promote  in  vivo  bone  ingrowth  and  subsequently  repair  or  regenerate  bone  to  replace
missing tissue, as they come in various types including degradable and non-degradable, can be easily modified and also
mass-produced [20 - 23]. Examples of synthetic polymers include, but are not limited to, polycaprolactone (PCL) [24,
25], poly (lactic-co-glycolic) acid (PLGA) [26, 27], polyamide, polyvinyl alcohol (PVA) [28, 29], polyurethane (PU)
[30,  31]  and  polyetheretherketone  (PEEK) [32,  33].  In  detail  investigation  of  these  polymers  and  others  of  similar
nature is beyond the scope of this article. However, Liu and Ma (2004) have done a comprehensive review on this topic
[17].
Although  synthetic  polymers  can  offer  wide  advantages,  including  controlled  degradation,  biocompatibility,
mechanical stability and many more, they lack osteoconductivity or osteoinductivity. Synthetic nHA, due to its close
chemical similarities to that of the natural bone, has attracted extensive research focus as a potentially suitable filler for
synthetic polymers to create nanocomposite materials for bone tissue engineering [20, 34, 35]. Creating nanocomposite
materials from incorporation of nHA into synthetic polymers could combine the advantages inherited by each of these
components. Therefore, the aim of the present article is to review and update various aspects involved in incorporation
of synthetic nHA into synthetic polymers, in terms of their potentials to promote bone growth and regeneration both in
vitro, in vivo and consequently in clinical applications. To this end, the most recent findings and research on this topic
have been investigated and discussed.
NANOHYDROXYAPATITE
nHA is the main inorganic compound of the natural bone, which exhibits a hexagonal crystal structure, and has a
chemical formula of Ca10(PO4)6(OH)2. nHA is produced using various methods such as mechanochemical synthesis,
combustion preparation and various wet chemistry techniques [20] and comes in variety of forms and shapes including
nanofibers, nanorods and nanoflakes [36, 37]. However, for the first time, nHA (nanocrystalline HA; particle size ~ 20
nm) was synthesised using calcium nitrate and diammonium hydrogen orthophosphate as precursors by solution spray
dry method [38].
nHA has been used in various aspects of bone tissue engineering research due to its stablished biocompatibility,
osteoconductivity, bone integration abilities, slow degradation, and non-cytotoxicity [18, 39, 40]. Furthermore it has
been stablished that, nHA, due to the size of its nanoparticles and consequently increased surface area as well as its
improved sinterability and enhanced densification (compared to HA powder), has increased fracture toughness and a
stronger ability to bond with proteins [41]. Other physiochemical characteristics of nHA such as its high melting point
(does not melt in human body), its hard and wear resistance as well as its ability to resists surface reaction with certain
fluids  in  the body,  render  nHA an interesting bioceramic material  for  bone tissue engineering (Table  2).  However,
properties such as its lack of flexibility and its brittleness make it difficult to form nHA into specific shapes for bone
tissue  engineering  on  its  own  [20].  These  limitations  could  be  overcome  by  incorporation  of  nHA  into  a  suitable
polymeric scaffold [42].
Table 2. Physiochemical characteristics of synthetic nanohydroxyapatite.
Melting temperature 1100-1650 ºC
Molecular weight 1004
Specific gravity 3.16 g/cm
Solubility at 25 ºC, -log(Ks) 116.8
Solubility at 25 ºC, g/L ~0.0003
pH stability range in aqueous solutions at 25 ºC 9.5-12
Ca/P ratio 1.67
Hydrophilicity/hydrophobicity Highly hydrophilic
nHA/SYNTHETIC POLYMERS INCORPORATION
In theory, most types of polymers can be incorporated with nHA. However, not all of them are suitable matrixes for
this purpose. In order to achieve a well dispersed nHA/polymer nanocomposite, various factors should be considered. A
critical issue to pay attention to in developing nHA/polymer nanocomposites is the interfacial strength between the filler
(nHA nanoparticles) and the polymer. A suitable polymer should have a chemical bonding composition that supports
adhesion between its particles and those of nHA [43]. Otherwise, the lack of adhesion can lead to early failure of the
two incorporated phases and hence affect the mechanical properties (in particular tensile strength) of the construct.
Furthermore, the wettability of a polymer can play a crucial role in successful incorporation of nHA by affecting the
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type and strength of bonding and adherence of the nHA surface and the polymer [44]. This phenomenon is determined
by the polarity and available polar groups of the polymer, which can render the polymer hydrophobic or hydrophilic.
In addition, the method of incorporation of nHA into the polymer could have great impact on the properties of the
final construct. The methods of delivering nHA into a polymer matrix can be divided into two main categories; thermo-
mechanical methods and physico-chemical methods [45, 46]. The former methods use conventional plastics processing
techniques  to  impregnate  a  porous  polymeric  matrix  with  nHA.  Examples  of  such  methods  are  compounding,
compression or injection moulding. Physico-chemical methods, on the other hand, use either co-precipitation of nHA
crystals in situ into the polymeric matrix or use a solvent as a dispersion solution for nHA before being added to the
polymer.  Both  thermo-mechanical  methods  and  physico-chemical  methods  have  been  shown  effective  for  nHA
incorporation  into  polymers,  however,  various  limitations  such as  thermal  degradability  of  heat-sensitive  polymers
caused by moulding temperature and pressure, solvent toxicity, and gelation rate exist [43].
nHA/SYNTHETIC POLYMERS DEGRADATION
Ideally the rate of scaffold degradation should be compatible with the rate of replacement of bone produced from
cells. This is a crucial factor to be noted when selecting or designing a suitable scaffold for bone tissue engineering
purposes as well as to ensure long-term success of the tissue engineered scaffold. Scaffold degradation can have great
impact on three-dimensional cell growth and angiogenesis; two crucial factors involved in bone tissue regeneration
[47]. Furthermore, the rate of degradation of construct could affect the mechanical properties of reconstructed bone
negatively, an event that could consequently lead to failure of bone regeneration and its integrity, especially in the cases
of load-bearing bone tissue engineering applications such as spinal fusion implants [48].
Depending on the nature of the selected polymer (i.e. slow degrading or fast degrading polymer), nHA/synthetic
polymer scaffolds would have different degradation profiles and hence different ability to allow for bone regeneration
and  remodelling.  Generally,  the  process  of  nHA/synthetic  polymer  scaffolds  degradation  takes  places  either  by
dissolution of the scaffold and subsequent the take up of the fragments by phagocytosis or macrophages or through
osteoclasts which are multinucleated monocyte-macrophage derivatives that degrade bone and use the fragments to
manage extracellular calcium activity [48 - 50].
A part from the nature of the synthetic polymer various other characteristics of the scaffold including the crystal size
of nHA, the surface roughness and topography of the scaffold could also impact the rate of degradation [48, 51 - 53].
The  size  of  nHA  crystals  could  determine  the  specific  surface  area  (SSA)  to  volume  ratio  of  the  scaffold  and
consequently  effect  the  scaffold  solubility  and  resorbability  [54].  A  higher  surface  area  to  volume  ratio  may
significantly increase solubility of the construct  and render it  more resorabable [55].  Furthermore,  degradation rate
could be affected by the Ca/P ratio by which solubility and degradation rate of the scaffold decreases with an increase in
the Ca/P molar ratio of nHA [54, 56].
Vast number of studies have been conducted and published on the process and rate of degradation as well as the
cytotoxicity of degraded micro- and nano-particles of nHA/synthetic polymers both in vitro and in vivo. Dong et al.
investigated porous nHA/PU (30:70 wt%) scaffolds from castor oil, for their degradation rate and biocompatibility and
reported that their scaffolds were non-cytotoxic and degradable [57]. In this study, scaffolds were seeded with bone
marrow stromal cells (BMSCs) after soaking in simulated body fluid (SBF) for 4 weeks. In vivo study was conducted
on healthy SD female mice for a 12 week period. Infrared spectroscopy of n-HA/PU scaffold and scaffold soaking in
SBF for 4 weeks showed that the long carbon chains of castor oil break into shorter chains, therefore, indicating that
urethanes degrade through chemical breakage of castor oil followed by the hydrolysis of urethane bonds joining the
hard  and  soft  segment.  Authors  further  investigation  of  nHA/PU  scaffold  revealed  that  in  vivo  degradation  of  the
construct  was  mainly  due  to  the  enzyme  digestion  of  n-HA  from  monocyte-derived  macrophage  (MDM)  and  the
hydrolysis of PU (Fig. 1). Han et al. also investigated the difference in degradation rate, affected by specific surface
area,  of  a  biomimetic  nanofibrous  poly(L-lactide)  scaffold  strengthened  by  nHA  particles  and  reported  that  the
nanofibrous poly(L-lactide) (NF-PLLA) had a significantly higher SSA (34.06 m
2 g-1) compared to that of poly(L-lactide)
(PLLA) scaffolds (2.70 m2 g-1) with platelet structure [58]. Furthermore, incorporation of nHA increased the SSA of the
scaffold. Their research revealed that both NF-PLLA and nHA/NF-PLLA had a faster significantly degradation rate,
due to their much larger SSA, compared to poly(L-lactide). Similarly, Diaz and Puerto (2015) examined the effect of
bioactive nanoparticles on the in vitro degradation of nHA/poly(L-lactide-co-ε-caprolactone) (nHA/PLCL) composite
scaffolds and found that the rate of degradation was significantly dependent on the concentration of nHA [59]. At 10%,
30% and 50% of total polymer mass the authors incorporated nHA into PLCL and observed that the rate of degradation
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of the scaffolds was significantly slower with the increase of nHA content compared to lower nHA concentrations and
that of pure PLCL (Fig. 2A & C). The authors also observed higher water absorption capability of the nHA particles at
higher  nHA  concentrations  and  consequently  affecting  the  degradation  rate  (Fig.  2B).  This  phenomenon  can  be
explained by the ability of nHA nanoparticles to absorb water molecules penetrating the solid structure of the scaffold
and hence slowing the degradation.
Fig.  (1).  Degradation  profile  of  nHA/PU scaffolds:  A)  Photo  macrograph image of  the  porous  n-HA/PU scaffold;  B)  Scanning
electron microscopy imaging of the porous n-HA/PU scaffold (1) and after 4 weeks of soaking in SBF (2, 3); C) Inferred spectra of
n-HA/PU scaffold (1) and after 4 weeks of soaking in SBF (2); D) Histological imaging of n-HA/PU scaffold (denoted as P) 12
weeks after in vivo implantation (R denotes muscle tissue, H&E stained). (1) x 40, (2) x 400 [57].
ENHANCED OSTEOCONDUCTIVITY OF nHA/SYNTHETIC POLYMERS
One of the most interesting characteristics of nHA is its osteoconductivity; the ability to facilitate bone repair and
bone growth on a surface (scaffold) or in other words to promote osteoconduction. This interest is mainly due to the fact
that most synthetic polymers, on their own, have low surface wettability (i.e. they are highly hydrophobic) [60] and on
their own are not favourable for bone tissue engineer application as they lack the ability to promote osteogenic cells
adhesion, proliferation and differentiation [60 - 62]. Furthermore, osteogenic cells have a higher apoptotic rate on such
hydrophobic surfaces than on those with higher surface wettability. This is where incorporation of nHA into synthetic
polymers  can  play  a  crucial  role,  in  facilitating  bone  growth,  by  rendering  the  scaffold  surface  more  or  highly
hydrophilic (depending on nHA concentration). Another factor critical in bone formation is the ability of the scaffold to
evoke tissue response. However, as most synthetic polymers have a bioinert surface they do not provide the necessary
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bioactive function for bone regeneration [60]. In the absence of nHA, synthetic polymers have limited abilities and are
only able of promoting minimal and disrupted bone regeneration. This also could be overcome by incorporation of nHA
into  synthetic  polymer  as  it  has  the  necessary  bioactive  functions  for  bone  formation  and  hence  promoting  tissue
responses. nHA/synthetic polymer scaffolds bond with the host tissue and promote the formation of a bone-like apatite
layer on the surface of the implant [60, 63, 64].
Fig. (2). Investigation into the effect of nHA nanoparticles on the degradation of PLCL: A) Profile of Mw versus degradation time
for PLC/nHA composite scaffolds; B) Changes of water absorption versus degradation time for PLCL/nHA composite scaffold; C)
Scanning electron microscopy imaging of PLCL surface morphology: (a) PLCL after two weeks of in vitro degradation, (b) PLCL/10
wt% nHA after four weeks of in vitro degradation (c) PLCL after six weeks of in vitro degradation, and (d)) PLCL/50 wt% nHA
after four weeks of in vitro degradation [59].
Increased  osteoconductivity  of  nHA/synthetic  polymer  scaffolds  has  been  a  promising  avenue  to  enhance  and
optimise bone grafts and implants for the purpose of bone tissue engineering. For instance, Tong et al. investigated the
in vitro biological effect of carbonated nHA (CHA) on poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV); a synthetic
polymer which lacks osteoconductivity that is optimum for bone tissue engineering [65]. The human osteoblast-like
cell-line  (SaOS-2)  was  cultured  onto  both  types  (electrospun  PHBV  and  CHA/PHBV)  of  scaffolds  and  their
morphology, proliferation and alkaline phosphatase (ALP) activity were measured in a period of 14 days at different
cell culture time points. The authors reported that after 14 days of culture, although both types of scaffolds promoted
cell adhesion, proliferation and spreading, the CHA/PHBV scaffolds exhibited a significantly higher ALP activity of
SaOS-2 cells  than the PHBV scaffolds,  therefore,  suggesting that  the presence of  CHA nanospheres in electrospun
CHA/PHBV nanocomposite fibers was useful for encouraging the expression of ALP activity of the cells. Zhang et al.
studied  porous  nHA/PCL  spiral  scaffolds  with  different  weight  ratios  of  nHA  and  PCL,  to  find  out  if  biological
activities of human fetal osteoblasts (hFOBs) are nHA dose dependent [66]. The authors reported that these scaffolds
supported hFOBs adhesion, viability and proliferation but what was interesting to notice was that ALP activity and
mineralised matrix synthesis of these cells were significantly increased on the nHA/PCL scaffolds compared to the
pristine  control.  LIVE/DEAD staining revealed significantly  higher  cell  viability  on nHA:PCL = 1:4  scaffolds  and
nHA:PCL = 1:2 scaffolds than on nHA:PCL = 1:8 scaffolds and PCL (Fig. 3A). ALP assay showed that ALP activity
was significantly higher in the nHA:PCL= 1:4 and nHA:PCL = 1:2 spiral scaffolds compared to nHA:PCL = 1:8 and
PCL spiral scaffolds (p>0.05) (Fig. 3B).  Moreover, qualitative Alizarin S Red staining of calcium deposition assay
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showed that the nHA/PCL spiral scaffolds had a higher average calcium deposition than that on the PCL spiral scaffolds
(p>0.05) (Fig. 3C). Using polymerase chain reaction, the authors also studied the osteoblastic cell differentiation on
mRNA level and found a similar trend whereby nHA/PCL nanocomposite scaffolds had a higher level of osteogenic
differentiation markers in an nHA dose dependent manner (Fig. 3D).
Fig. (3). Investigation into the in vitro effect of nHA nanoparticles on PCL: A) Cells seeded on PCL spiral scaffold (1), HA:PCL =
1:8 nano-HA/PCL spiral scaffold (2), HA:PCL = 1:4 nano-HA/PCL spiral scaffold (3), HA:PCL = 1:2 nano-HA/PCL spiral scaffold
(4) for 7 days. Live cells were stained green, dead cells were stained red and nucleus were stained blue; B) ALP expression on the
nano-HA/PCL spiral scaffolds (normalised against protein concentration) after 2 and 3 weeks in vitro. Data represent the mean ±
standard deviation, n = 6. Significant difference between different material groups were denoted as * (p<0.05); C) Alizarin S Red
staining of cells cultured on PCL spiral scaffold (1), HA:PCL = 1:8 nano-HA/PCL spiral scaffold (2), HA:PCL = 1:4 nano-HA/PCL
spiral scaffold (3), HA:PCL = 1:2 nano-HA/PCL spiral scaffold (4) for 21 days; D) Gene expression of osteogenic markers in nano-
HA/PCL spiral scaffolds analysed using representative electrophoresis gel after 3 weeks in culture [66].
Furthermore, Selvakumar et al. researched mechanical properties, osteoconductivity and biocompatibility of two
types of 2-dimensional (2-D) rod-like nHA (unmodified and polypropylene glycol (PPG) wrapped) incorporated into
thermoplastic polyurethane (TPU) matrices based on polycarbonate soft segments both in-situ and ex-situ [67]. The
authors reported of enhanced osteoconductivity of the nanocomposites by successful formation of an apatite layer on
the surface of the scaffolds, after immersion into SBF. They also investigated the in vitro bioactivity of nanocomposites
by incubating the scaffolds in SBF solution with ion concentrations equal to human blood plasma and quantitatively
examined apatite layer formation on the surface the scaffolds. It was shown that the nHA-filled TPU nanocomposites
prepared by the in situ technique had an abrupt change in the apatite layer formation compared to pristine TPU.
ENHANCED MECHANICAL PROPERTIES OF nHA/SYNTHETIC POLYMERS
Natural bone has an architectural design consisting of nanoscale to macroscopic dimensions, which provide it with
stable mechanical properties. In order to mimic the nanostructure in natural ECM and mechanical characteristics of the
natural  bone,  vast  research  has  focused  on  manipulating  polymeric  scaffolds  at  the  nanostructure  dimension,  for
instance by incorporation of nanoparticles, nanotubes and nanofibers into the polymer matrix [68].
As discussed, nHA has low strength and toughness due to its poor sinterability, however, these drawbacks can be
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overcome by designing a nanocomposite in which nHA would provide excellent bioactivity and osteoconductivity and
the  polymer  would  offer  the  necessary  mechanical  strength  to  the  brittle  nHA  and  the  scaffold  as  a  whole.  Such
nanostructured materials, due to high surface energy, could potentially have all the requirements needed for particular
applications in bone tissue engineering. Incorporation of nHA into a polymer matrix can have various effects on the
mechanical  properties  of  the  construct  depending  on  different  factors  including  but  not  limited  to;  the
structure/morphology  of  nHA,  method  of  dispersion  and  the  size  and  the  concentration  of  the  nanoparticles.
Fig. (4). Mechanical properties, aggregate/cluster formation and biodegradability of SP nanocomposites with different nHA content:
A)Tensile modulus of SP nanocomposites with different nHA content; B) Tensile strength of SP nanocomposites with different nHA
content;  C)  Top  new  aggregate/cluster  formation  between  PCL(UPy)2  and  HApUPynano-particles  in  supramolecular  nano-
composites; bottom temperature stability of the supramolecularly assembled aggregates/ clusters; D) biodegradability evaluation in
terms of hardness and moduli data of the 60/120 days incubated samples in comparison with fresh samples (a and b),  the MTT
viability test on PBS solutions equilibrated with the neat PCL(UPy)2, PU10 and PH10 and pure PBS solution (c). Fresh PBS solution
and culture medium were used as controls. The viability of rBMSCs in culture medium (DMEM) was set at 100% [72].
Liu et al. investigated dispersion of nHA in PLGA and its effect on mechanical properties compared to composites
with  agglomerated  ceramic  nanoparticles  [69].  The  authors  demonstrated  that  well-dispersed  nHA  in  PLGA
significantly improved mechanical properties, in specific the tensile modulus, tensile stress at yield, ultimate tensile
strength and compressive modulus of the constructs. This consequently led to greater osteoblast functions vital for bone
regeneration. Nathanael et al. studied nHA nanorods reinforced with high molecular weight polyethylene (HMWPE)
and  found  that  the  tensile  strength  and  the  abrasion  resistance  were  improved  in  these  scaffolds  compared  to  pure
HMWPE specimen and nHA [70]. The authors also reported that the mechanical strength and the homogeneous mixing
with the polymer matrix were also dependent on the particle size and shape, in a manner by which the smaller size
nanorod  particles  provided  a  well  homogenous  mixture  of  HA  and  HMWPE  and  consequently  better  mechanical
strength.  Furthermore,  Sajjadi  et  al.  researched  the  role  of  nHA  concentration  on  the  mechanical  properties  of
polymethylmethacrylate/nHA (PMMA/nHA) nanocomposites by homogenously distributing increasing concentrations
of nHA (0, 2.5, 5, & 10 wt% nHA) into PMMA [71]. The authors observed that increased nHA concentration decreased
wear rate in both atmosphere and artificial saliva, as the presence of nHA has high hardness that can improve sliding
wear rate. However, they did not observe any direct proportionality between the results of compression tests and the HA
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content and the addition of up to 10% wt nHA to PMMA did not affect the bending properties significantly. Shokrollahi
et al. recently studied the effect of interfacial interactions of nHA and synthetic PCL matrix in terms of the mechanical
properties and biodegradation of the nanocomposite [72]. To do this, the authors prepared nHA/ureido pyrimidinone
(HApUPy) hybrid biocomposites composed of surface-modified nHA and supramolecular PCL (SP PCL) at different
compositions  and  evaluated  their  mechanical,  thermal  and  viscoelastic  properties  as  well  as  biodegradability,
biocompatibility  and  cytotoxicity  in  vitro  and  compared  to  SP  PCL/naked  hydroxyapatite  nano-composites.  They
showed that surface modification of nHA resulted in significant improvement of tensile strength and modulus of the
nanocomposite  of  up  to  3.6  and  2.2–fold,  respectively  (Fig.  4A & B).  It  was  also  demonstrated  that  formation  of
microphase,  due  to  separation  of  supramolecular  clusters  around  the  modified  surface  of  nHA  nanoparticles,  was
responsible for the significant improvement in mechanical properties at room temperature (Fig. 4C). Moreover, nano-
indentation  measurements  revealed  that  the  hardness  and  moduli  of  the  nanocomposites  increased  with  increasing
concentration of nHA (Fig. 4Da & b) as the nHA bioceramic nanofiller incorporation into the polymer enhanced the
strength of the scaffolds. In vitro culturing showed no toxic effects on mesenchymal stem cells (Fig. 4Dc). Jiang et al.
explored  a  novel  method  of  surface-grafting  for  nHA incorporated  into  PLGA and  investigated  the  effect  of  such
surface modification on the dispersion of nHA and the enhancement of mechanical properties of the polymer [44]. The
authors  reported  of  a  new  method  of  surface-grafting  D,  L-lactide  (DLLA)  for  nHA  with  the  help  of  citric  acid.
Investigation into the dispersion of the modified nHA (g1-n-HA) and the mechanical enhancement effect of this method
on PLGA revealed that the use of citric acid increased grafting amount and improved dispersion of nHA compared to
surface-grafting  of  nHA without  citric  acid,  as  unmodified  nHA nanoparticles  formed  aggregation  phenomenon  in
dichloromethane, but the dispersion of g1-n-HA are obviously improved after surface-grafting with citric acid (Fig. 5A
& B). Interestingly, their research also showed a remarkable 20% improvement on the bending strength and tensile
strength of nHA/PLGA scaffolds modified with citric acid compared to pure PLGA with 3 wt% nHA. Even with 15
wt%  nHA,  pure  PLGA  had  8  and  6%  lower  bending  strength  and  tensile  strength,  respectively,  compared  to
DLLA/citric  acid  modified  nHA/PLGA  scaffolds.  Furthermore,  assistance  of  citric  acid  for  surface  modification
showed better mechanical properties compared to nHA/PLGA scaffolds with the nHA modified without the use of citric
acid (Fig. 5C & D). Based on their findings, Jiang et al. proposes that nHA/PLGA scaffolds prepared using their novel
method has a great potential in bone fracture internal fixation application in the future.
Fig.  (5).  Internal  structure  imaging  and  mechanical  properties  profiling  of  different  g-n-HA content:  A)  Transmission  electron
microscopy  images  of  unmodified  n-HA;  B)  Transmission  electron  microscopy  images  of  g1-n-HA;  C)  Mechanical  properties
(bending strength) of different g-n-HA content; D)) Mechanical properties (tensile strength) of different g-n-HA content (red curve is
g1-n-HA, and black curve is g2-n-HA) [44].
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CLINICAL APPLICATIONS OF nHA/SYNTHETIC POLYMER SCAFFOLDS
As discussed earlier,  scientific research, through extensive physiochemical characterisation, in vitro  and in vivo
assessment, has brought together the optimum characteristics of nHA and various types of synthetic polymers in order
to develop nanocomposites of suitable nature for bone tissue engineering (Table 3). Most if not all of these efforts have
been put into place in order to develop, design and manufacture an end product suitable for human clinical applications.
For instance, nHA/synthetic polymers of suitable nature have become candidates of enormous potentials as bone graft
substitutes, or as a coating materials for dental and orthopaedic implants [73 - 75]. Statistical reports show that every
year around the world, approximately 15 million bone fractures occur [76], of which up to 10% fail to heal completely
and hence lead to complications of non-union healing [77, 78]. Commonly, non-union fractures are characterised by the
significant  gap  between  the  fracture  bone  ends,  which  would  not  naturally  close  unless  a  platform  is  introduced
surgically to act as a temporary support and to bridge this distance [78]. This is where synthetic nHA/polymer bone
graft  substitutes  come  into  play  a  significant  role  in  clinical  applications  and  as  an  alternative  for  allografts  and
autografts currently used. Most of the bone graft substitutes used in clinical applications are granules (0.1 to 5 mm in
diameter) or porous blocks [79]. In some cases, bone graft substitutes come in the form of injectable with the ability to
harden after implantation in situ or injection. Others come in the form of a mesh or a paste that cannot be hardened. The
latter type consist of the granules and a highly viscous hydrogel “glue” [79, 80]. As a coating agent nHA/synthetic
polymer  constructs  are  able  to  form  a  sintered  apatite  layer  to  create  a  tight  and  durable  bonding  between  the
implant/prosthesis (of various material e.g. metals or polymers) and the living bone tissue [81]. Liu et al. and Pepla et
al.  have done comprehensive reviews on the nature,  design,  development,  advantageous and disadvantages of such
scaffolds for specific clinical applications [40, 78].
Table  3.  The most  recent  and significant  studies  on degradation profile,  osteoconductivity  and mechanical  properties  of
synthetic nanohydroxyapatite incorporated into various types of synthetic polymers.
Author Scaffold Fabrication Technique Major Tests Significant Findings
Degradation Dong et al.
(2009) [51]
nHA/PU Foaming SBF, in vitro, in
vivo
SBF test indicated that urethanes
degrade through chemical breakage of
castor oil followed by the hydrolysis of
urethane bonds joining the hard and
soft segment.
in vivo degradation of the construct was
mainly due to the enzyme digestion of
n-HA.
Han et al.
(2013) [52]
PLLA, NF-PLLA &
nHA/NF-PLLA
Thermally induced phase
separation
Physiochemical
& in vitro
Nanofibrous poly(L-lactide) and
nHA/poly(L-lactide) had a significantly
faster degradation rate, due to their
much larger SSA, compared to poly(L-
lactide).
Huang et al.
(2013) [95]
nHA/ PLLA Melt blending In vitro nHA/PLLA scaffold had a slower rate
of degradation than the PLLA scaffold.
The nHA/PLLA material sustained its
initial mechanical strength better than
the pure PLLA scaffold.
Diaz et al.
(2014) [96]
PLLA & nHA/PLLA Lyophilization Phosphate buffer
Solution
By forming a physical barrier, the nHA
nanoparticles decreased the rate of
degradation of PLLA scaffolds.
Diaz &
Puerto
(2015) [53]
PLCL & nHA/PLCL Thermally induced phase
separation
In vitro The concentration of nHA significantly
affected the degradation rate. The rate
of degradation of the scaffolds was
significantly slower with the increase
of nHA content compared to lower
nHA concentrations and that of pure
PLCL
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Author Scaffold Fabrication Technique Major Tests Significant Findings
Osteoconductivity Tong et al.
(2011) [59]
Electrospun PHBV
& CHA/PHBV
Nanomulsion/electrospinning In vitro CHA/PHBV scaffolds exhibited a
significantly higher ALP activity of
SaOS-2 cells than the PHBV scaffolds,
therefore, suggesting that the presence
of CHA nanospheres in electrospun
CHA/PHBV nanocomposite fibers was
useful for encouraging the cells for the
expression of ALP activity.
Fu et al.
(2012) [97]
PCEC & nHA/PCEC Melt blending/ electrospinning In vitro & in vivo The nHA/PCEC composite scaffolds,
implanted in 12 New Zealand white
rabbits, had a higher ability to promote
guided bone regeneration than that of
self-healing control group with no
implant.
Zhang et al.
(2014) [60]
PCL & nHA/PCL Air drying/coagulation In vitro Scaffolds supported hFOBs adhesion,
viability and proliferation but ALP
activity and mineralised matrix
synthesis of these cells was
significantly increased on the
nHA/PCL scaffolds compared to
pristine control. nHA/PCL
nanocomposite scaffolds had a higher
level of osteogenic differentiation
markers and the effect was nHA dose
dependent.
Selvakumar
et al. (2015)
[61]
TPU & nanorods
nHA/TPU
non-ionic surfactant & in situ In vitro Enhanced osteoconductivity of the
nanocomposites by successful
formation of an apatite layer on the
surface of the scaffolds was reported
after immersion into SBF.
Mechanical
Properties
Liu et al.
(2010) [63]
nHA/PLGA & Wet chemistry precipitation Physiochemical Well-dispersed nHA in PLGA
significantly improved tensile modulus,
tensile stress at yield, ultimate tensile
strength and compressive modulus of
the constructs.
Nathanael
et al. (2011)
[64]
nHA
nanorods/HMWPE
& HMWPE
Horizontal injection
moulding
Physiochemical Studied nHA nanorods reinforced with
high molecular weight polyethylene
(HMWPE) and found that the tensile
strength and the abrasion resistance
were improved in these scaffolds
compared to pure HMWPE specimen
and nHA.
Sajjadi et al.
(2011) [65]
nHA/PMMA &
PMMA
Compression molding Physiochemical It was shown that increased nHA
concentration of PMMA/nHA scaffolds
decreased wear rate in both atmosphere
and artificial saliva, as the presence of
nHA has high hardness that can
improve sliding wear rate.
Shokrollahi
et al. (2014)
[66]
HApUPy & SP
PCL/naked nHA
Drying under reduced pressure Physiochemical
& in vitro
Unusually improved mechanical
properties were observed in nHA/PCL
scaffolds which was explained by the
formation of supramolecular clusters
around nHA nanoparticles.
Jiang et al.
(2014) [67]
Unmodified
nHA/PLGA, g1-n-
HA & g2-n-HA
Surface grafting DLLA with
and without citric acid
Physiochemical A novel method of surface-grafting for
nHA incorporated into PLGA showed a
20% improvement on the bending
strength and tensile strength of
nHA/PLGA scaffolds modified with
citric acid compared to pure PLGA
with 3 wt% nHA.
One of the main clinical applications of nHA/synthetic polymer constructs, either as building material, bone graft
substitute or as a coating agent, is in spinal fusion surgery [82]. Spinal fusion is a motion eliminating procedure where
two vertebrae are fused together by introducing bone grafts to promote bone growth. Autogenous iliac crest graft is
considered the “gold standard” bone graft for spinal fusion [83, 84]. However, due to the limitations and drawbacks of
this  type  of  bone  grafts,  synthetic  nHA/polymer  bone  graft  substitutes  are  becoming  more  and  more  popular.  The
(Table 3) contd.....
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process of bone fusion can be further supported and encouraged by using plates, screw, rods and/or cages of suitable
types and sizes. One of the most commonly used instrument in spinal fusion surgeries is the cage, a device designed by
Bagby et al. with a hollow cylindrical structure to overcome the risks of donor site morbidity associated with iliac crest
grafts [85]. It is referred to as “cage” as this device has been designed to allow bone graft to be placed inside its hollow
structure. The first cage was made out of stainless steel, however, it was gradually replaced by the titanium mesh cage
due to the excellent mechanical properties and preferable clinical outcomes of titanium [84, 86]. In the recent years,
nHA/synthetic  polymers,  due  to  their  stress  shielding,  mechanical  properties,  osteoconductivity,  bioactivity  and
degradability,  have  been  used  as  building  material  for  spinal  fusion  cages  [87].  Yang  et  al.  investigated
nHA/polyamide-66 (nHA/PA66) cage, a hollow cylindrical device consisting of nanoparticle HA and polyamide-66 for
single level anterior cervical discectomy and fusion (ACDF) (Fig. 6A) [84]. Forty seven consecutive patients (mean age
of 47.7 years) with radiculopathy or myelopathy were the subjects of this investigation into each of whom a nHA/PA66
cage was placed in a single level ACDF procedure (Fig. 6B). Patients were divided into two groups; Group A) those
who had been fused using nHA/PA66 cage with pure local bone graft (n= 27) and Group B) those who had been fused
using  nHA/PA66  cage  with  hybrid  bone  grafts  (n=  20).  The  segmental  lordosis  and  intervertebral  disc  height  was
measured on each patient preoperative using radiographs. The loss of segmental lordosis correction and spinal cage
subsidence was measured over a two year follow-up period. The mean correction of segmental lordosis from surgery,
the mean loss of correction, the mean cage subsidence and the rate of cage subsidence (>2 mm) were 6.9 ± 3.0°, 1.7 ±
1.9°,  1.2  ±  0.6  mm  and  2%,  respectively.  The  authors  reported  a  100%  rate  of  fusion  success  (Fig.  6C)  and  no
significant difference amongst the two groups. This cage was found to have a low modulus of elasticity (5.6 GPa), a
measure which is significantly lower than that of the bone graft (12 GPa). This is an important finding as the lower
modulus of a cage can help to decrease stress shielding and consequently encourages early osseous fusion. Interestingly,
it was observed that by implanting the nHA/PA66 cage in patients and by the nHA of the cage coming into contact with
the surrounding body fluids, a process of micro-ion-exchange of Ca2+ and PO43 took place in the interbody space that
formed a crystal layer on the surface of the cage, which assisted the creeping growth of bone graft. Based on these and
also due to a high rate of success and a low rate of subsidence, as well as the radiolucency of this cage (allowing for
clear X-ray film and CT scans to assess osseous fusion or spinal decompression status), the authors concluded that the
nHA/PA66 cage is a suitable reconstructing instrument for patients undergoing ACDF. In a separate study, Xu et al.
investigated  the  safety  and  efficiency  of  porous  nHA/PA66  cage  in  rabbits  and  report  primary  use  in  cervical
discectomy and fusion [88].  nHA/PA66 biocomposite with a high compressive strength (13-46 MPa) and excellent
porosity  (pore  size  of  280-500 µm and porosity  of  36-57%) was  used  to  manufacture  columnar  nHA/PA66 blocks
(height of 10 mm and diameter of 5 mm). Thirty New Zeeland white rabbits, each with four defect holes previously
drilled in the femur, were used as animal models in each of which two nHA/PA66 blocks were introduced and the other
two defects were left empty. The rabbits were divided into three groups depending on the sacrifice time (4, 12 and 24
weeks). All subjects survived until the end of their sacrifice period with good wound healing and no complication was
encountered during the postoperative period. Macroscopic observation of the defects at the end of week 4 should 70%
of the surface of the implant covered with callus formation and very few calluses observed in the blank control defects.
At the end of 12 weeks the defects with the implants showed near complete surface coverage of the cage by callus but
fewer calluses in the blank control. At twentieth week natural bone had covered the defect in the nHA/PA66 groups,
whereas  in  the  other  group only  thin  callus  was  observed.  From these  findings,  authors  concluded that  nHA/PA66
biocomposite,  due  to  the  bioactivity  of  nHA  and  the  construct  excellent  porosity,  connectivity,  pore  size  and
compressive strength could provide good support as bone graft substitute during the bone healing process. Furthermore,
the irregular shape of the blocks provided a good interface between the bone graft substitute and the host bone, hence
allowing the new bone tissue to survive in the interconnected pores. More importantly, since just after four weeks new
bone  was  formed  around  the  implant  and  inside  the  pores,  the  good  osteoconductivity  of  the  bone  substitute  was
evident.  Furthermore, for the primary clinical study, a prospective non-random compared study of 60 patients with
cervical spondylosis myelopathy or radiculopathy who underwent ACDF with cage and anterior plate was conducted.
Here, the anterior fusion was carried out using nHA/PA66 cage in thirty of the patients and PEEK cage in the remaining
thirty. Complete datasets (preoperative, immediately, postoperative and 3 & 6 months follow-up) were obtained for 57
out  of  60  patients  eligible  for  inclusion.  Out  of  this  57  patients,  29  underwent  the  ACDF with  PEEK cage  and  28
patients  with  nHA/PA66  cage.  There  were  no  serious  complications  in  either  of  the  two  groups  and  radiographic
analysis showed no cage migration or breakage for either of the groups at the end of 6 months follow-up period. At the
end of 3 month follow-up period, the nHA/PA66 group showed a higher rate of fusion (93%) compared to that of the
PEEK group  with  83% successful  fusion  rate.  The  two group  showed 100% fusion  rate  at  the  end  of  the  6  month
follow-up period. The authors concluded that nHA/PA66 bone graft was highly safe and effective in repairing bone
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defects of rabbits. Furthermore, the porous nHA/PA66 cage was effective when used in ACDF and had a good outcome,
however, the follow-up period was short to draw any conclusions for the long-term success of the cage.
Fig. (6). Outcome of single level anterior cervical discectomy and fusion using nanohydroxyapatite/polyamide-66 cage: A)Hollow
cylinder n-HA/PA66 cage with wide rims and several shallow recesses designed to avoid subsidence and migration; B) Implantation
of n-HA/PA66 cage (Black asterisk denotes the cage); C) Preoperative lateral radiograph of cervical spine of a cervical myelopathy
due to C5/6 disc herniation (a), Preoperative cervical T2W MRI cervical spine sagittal cut showing prolapse of C5-6 disc associated
with  edema signal  of  the  spinal  cord  (b),  Postoperative  x-ray  cervical  spine  lateral  view three  years  followup showing anterior
discectomy and fusion (c), Sagittal reconstruction computed tomography scans at three years followup showing good level of fusion
(d) [84].
As  mentioned  earlier,  nHA/synthetic  polymer  nanocomposites  can  be  used  as  coating  materials  for  dental  and
orthopaedic  implants.  PEEK has  been  frequently  used  in  spinal  fusion  surgery  and has  demonstrated  good clinical
results.  Its  chemical resistance,  mechanical  properties and radiolucency has made PEEK a suitable replacement for
metal implants [89]. Moreover, metal implants have significantly high elastic modulus (e.g. commercially pure titanium
E= 114 GPa), whereas PEEK has an elastic modulus of 3.2 GPa, which is a value in between that of the cortical and
cancellous bone, hence has more potential to match the host tissue. Despite these advantages of PEEK, this material is
bioinert and hydrophobic and has poor osseointegration in its pure form [89, 90]. To overcome these shortcomings
incorporation of nHA into PEEK has been considered, which successfully increased bone incorporation, however, some
studies have reported of reduced mechanical properties or physical bonding between the implanted and the coated layer
of nHA [91 - 94]. Very recently, Johansson et al. reported of a use of unique coating procedure that creates a very thin
layer of nHA coating (20-40 nm) and investigated the biological effects of nHA coating on PEEK implants in a rabbit
model. Briefly, nHA dispersion was applied to the implants by spin coating followed by 10 minutes drying at room
temperature [95]. The coated implants were then treated with heat to increase nHA crystals adherence to the polymer
surface. In vivo  study showed a significant improvement in early bone integration for nHA coated PEEK implants,
compared to uncoated PEEK implants probably due to the up-regulatory effect of dissolutioned nHA ions on osteoblast
activity. The study may be of clinical interest for coatings of instruments/implants of load-bearing nature which lack
bioactivity, bone integration and osseointegration abilities to ensure the long term success of the implant and avoid
repeated surgical treatments.
CONCLUSION AND FUTURE PERSPECTIVES
In the search for an ideal scaffold for bone tissue engineering, incorporation of nHA into synthetic polymers has
shown promising bioactivity, osteoconductivity and mechanical properties compared to other techniques previously
considered. Great deal of research has focused on the different avenues of incorporation of these two materials together
and various types of nHA/synthetic polymer nanocomposites, with enhanced in vitro and in vivo characteristics have
been developed. However, most of these nanocomposites lack the necessary requirements for human applications. This
is mainly because in vitro and in vivo experiments have limited abilities to simulate what would eventually happen to
the scaffold once implanted in humans. Furthermore, most clinical trials of scaffolds constructed from nHA/synthetic
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polymers have only been investigated for a short follow-up period (on average up to two years). This could be sufficient
for constructs of degrading nature, however, those of non-degradable nature require longer follow-up period in order to
determine the success or failure of the implant. Another issue worth noting is that most of the research focus has been
placed on biodegradable scaffolds. This could be of an issue for cases where bone defect is much larger than average
and in cases where the degradation rate of the scaffold does not match the rate of bone growth. To overcome this issue,
non-degradable scaffolds can be employed whereby permanent support can be provided to restore the functionality of
the  defected  bone.  A  potentially  suitable  candidate  for  such  an  application  could  be  nHA incorporated  polyhedral
oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU) nanocomposite. POSS-PCU is a novel polymer
with enhanced biocompatibility, superior mechanical engineering properties, and augmented degradative resistance, all
of which render it capable of functioning as a scaffold for nanoparticles loading for biomedical applications, a suitable
coating for medical devices and bioartificial organs [96, 97]. POSS-PCU, due to its desirable properties, has already
been successfully implemented in humans in the form of bypass graft, lacrimal duct and most notably, as the world's
first synthetic trachea [96, 98, 99]. Incorporation of POSS-PCU with nHA would offer great benefits both in terms of
the overall mechanical strength of the nanocomposite and enhanced material-cell response, mediated by POSS-PCU and
nHA,  respectively.  Developed  at  our  research  centre,  nHA/POSS-PCU  nanocomposite  (at  different  nHA
concentrations)  has  been investigated for  bone tissue engineering purposes  (such as  bone graft  substitutes,  implant
coating or guided bone regeneration (GBR)) and potentially promising in vitro results in terms of SaOS-2 osteogenic
cells attachment, proliferation and bone mineralisation have been achieved (results unpublished). As discussed, nHA
based nanocomposites have already shown promising in vitro, in vivo and clinical results, therefore, their translation for
human applications is bound to expand in the near future. One interesting factor to further improve the clinical use of
these materials is their enhanced interaction with mesenchymal stem cells [100, 101]. Stem cells are playing a crucial
role in furthering the achievements in the field of bone tissue engineering and regeneration with clinical translation as
the end goal. As the results, we aim to investigate the material-cell interaction of nHA/POSS-PCU nanocomposites with
mesenchymal stem cells. It is anticipated, from previous in vitro and in vivo growth of stem cells on POSS-PCU, that
the physicochemical and biological properties of these nanocomposite scaffolds could further enhance mesenchymal
stem cells differentiation towards osteoblast lineage for dental and orthopaedic applications [102 - 104].
LIST OF ABBREVIATIONS
(2-D) = 2-dimensional
(ALP) = Alkaline phosphatase
(ACDF) = Anterior cervical discectomy and fusion
(BMSCs) = Bone marrow stromal cells
(CHA) = Carbonated nHA
(DLLA) = D, L-lactide
(ECM) = Extracellular matrix
(GBR) = Guided bone regeneration
(HMWPE) = High molecular weight polyethylene
(hFOBs) = Human fetal osteoblasts
(MDM) = Monocyte-derived macrophage
(NF-PLLA) = Nanofibrous poly(L-lactide)
(nHA) = Nanohydroxyapatite
(nHA/PLCL) = nHA/poly(L-lactide-co-ε-caprolactone)
(HApUPy) = nHA/ureido pyrimidinone
(SaOS-2) = Osteoblast-like cell-line
(PHBV) = Poly (hydroxybutyrate-co-hydroxyvalerate)
(PLGA) = Poly (lactic-co-glycolic) acid
(PVA) = Polyamide, polyvinyl alcohol
(PCL) = Polycaprolactone
(PEEK) = Polyetheretherketone
(POSS-PCU) = Polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane
(PMMA/nHA) = Polymethylmethacrylate/nHA
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(PPG) = Polypropylene glycol
(PU) = Polyurethane
(SBF) = Simulated body fluid
(SSA) = Specific surface area
(TPU) = Thermoplastic polyurethane
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